Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study

Background Metabolomics helps to identify links between environmental exposures and intermediate biomarkers of disturbed pathways. We previously reported variations in phosphatidylcholines in male smokers compared with non-smokers in a cross-sectional pilot study with a small sample size, but knowle...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC medicine Jg. 11; H. 1; S. 60
Hauptverfasser: Xu, Tao, Holzapfel, Christina, Dong, Xiao, Bader, Erik, Yu, Zhonghao, Prehn, Cornelia, Perstorfer, Katrin, Jaremek, Marta, Roemisch-Margl, Werner, Rathmann, Wolfgang, Li, Yixue, Wichmann, H -Erich, Wallaschofski, Henri, Ladwig, Karl H, Theis, Fabian, Suhre, Karsten, Adamski, Jerzy, Illig, Thomas, Peters, Annette, Wang-Sattler, Rui
Format: Journal Article
Sprache:Englisch
Veröffentlicht: London BioMed Central 04.03.2013
BioMed Central Ltd
Springer Nature B.V
Schlagworte:
Adult
Aged
Aged, 80 and over
Biomedicine
Cardiovascular disease
Cohort Studies
Female
Health aspects
Humans
Male
Medicine
Medicine & Public Health
Metabolites
Metabolome
Middle Aged
Research Article
Serum - chemistry
Smoking
Smoking - adverse effects
Smoking Cessation
Smoking cessation programs
Studies
Canada
Germany
molecular epidemiology
metabolomics
smoking cessation
smoking
metabolic network
ISSN:1741-7015, 1741-7015
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Metabolomics helps to identify links between environmental exposures and intermediate biomarkers of disturbed pathways. We previously reported variations in phosphatidylcholines in male smokers compared with non-smokers in a cross-sectional pilot study with a small sample size, but knowledge of the reversibility of smoking effects on metabolite profiles is limited. Here, we extend our metabolomics study with a large prospective study including female smokers and quitters. Methods Using targeted metabolomics approach, we quantified 140 metabolite concentrations for 1,241 fasting serum samples in the population-based Cooperative Health Research in the Region of Augsburg (KORA) human cohort at two time points: baseline survey conducted between 1999 and 2001 and follow-up after seven years. Metabolite profiles were compared among groups of current smokers, former smokers and never smokers, and were further assessed for their reversibility after smoking cessation. Changes in metabolite concentrations from baseline to the follow-up were investigated in a longitudinal analysis comparing current smokers, never smokers and smoking quitters, who were current smokers at baseline but former smokers by the time of follow-up. In addition, we constructed protein-metabolite networks with smoking-related genes and metabolites. Results We identified 21 smoking-related metabolites in the baseline investigation (18 in men and six in women, with three overlaps) enriched in amino acid and lipid pathways, which were significantly different between current smokers and never smokers. Moreover, 19 out of the 21 metabolites were found to be reversible in former smokers. In the follow-up study, 13 reversible metabolites in men were measured, of which 10 were confirmed to be reversible in male quitters. Protein-metabolite networks are proposed to explain the consistent reversibility of smoking effects on metabolites. Conclusions We showed that smoking-related changes in human serum metabolites are reversible after smoking cessation, consistent with the known cardiovascular risk reduction. The metabolites identified may serve as potential biomarkers to evaluate the status of smoking cessation and characterize smoking-related diseases.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1741-7015
1741-7015
DOI:10.1186/1741-7015-11-60